These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34165483)

  • 1. Recent advancements of nanomaterial-based therapeutic strategies toward sepsis: bacterial eradication, anti-inflammation, and immunomodulation.
    Zhao Y; Pu M; Zhang J; Wang Y; Yan X; Yu L; He Z
    Nanoscale; 2021 Jun; 13(24):10726-10747. PubMed ID: 34165483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomaterial-based methods for sepsis management.
    Alipourfard I; Darvishi M; Khalighfard A; Ghazi F; Mobed A
    Enzyme Microb Technol; 2024 Mar; 174():110380. PubMed ID: 38147783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology.
    Pant A; Mackraj I; Govender T
    J Biomed Sci; 2021 Jan; 28(1):6. PubMed ID: 33413364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory and Therapeutic Effects of Mesenchymal Stem Cells on Organ Dysfunction in Sepsis.
    Khosrojerdi A; Soudi S; Hosseini AZ; Eshghi F; Shafiee A; Hashemi SM
    Shock; 2021 Apr; 55(4):423-440. PubMed ID: 32826813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation-responsive drug delivery nanosystems for treatment of bacterial-induced sepsis.
    Nyandoro VO; Omolo CA; Ismail EA; Yong L; Govender T
    Int J Pharm; 2023 Sep; 644():123346. PubMed ID: 37633537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-conventional immunomodulation in the management of sepsis.
    Slim MA; Turgman O; van Vught LA; van der Poll T; Wiersinga WJ
    Eur J Intern Med; 2024 Mar; 121():9-16. PubMed ID: 37919123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of peptides in nanosystems for diagnosing and managing bacterial sepsis.
    Gafar MA; Omolo CA; Elhassan E; Ibrahim UH; Govender T
    J Biomed Sci; 2024 Apr; 31(1):40. PubMed ID: 38637839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-camouflaged biomimetic nanoparticles as potential immunomodulatory solutions for sepsis: An overview.
    Wang Y; Liu L; Zheng X; Liu X
    Front Bioeng Biotechnol; 2023; 11():1111963. PubMed ID: 36970623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments and Trends of Nanotechnology Application in Sepsis: A Comprehensive Review Based on Knowledge Visualization Analysis.
    Fu J; Cai W; Pan S; Chen L; Fang X; Shang Y; Xu J
    ACS Nano; 2024 Mar; 18(11):7711-7738. PubMed ID: 38427687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA-based and bifunctional nanomedicine for alleviating multi-organ injury in sepsis under diabetic conditions.
    Li R; Li W; Zhou Y; Liao G; Peng G; Zhou Y; Gou L; Zhu X; Hu L; Zheng X; Wang C; Tong N
    Acta Biomater; 2024 Mar; 177():377-387. PubMed ID: 38307477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches to the development of anti-sepsis drugs.
    Lehmann C; Sharawi N; Al-Banna N; Corbett N; Kuethe JW; Caldwell CC
    Expert Opin Drug Discov; 2014 May; 9(5):523-31. PubMed ID: 24697209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances and prospects in nanomaterials for bacterial sepsis management.
    Zhou C; Liu Y; Li Y; Shi L
    J Mater Chem B; 2023 Nov; 11(45):10778-10792. PubMed ID: 37901894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of Schistosoma japonicum cystatin on bacterial sepsis in mice.
    Li H; Wang S; Zhan B; He W; Chu L; Qiu D; Li N; Wan Y; Zhang H; Chen X; Fang Q; Shen J; Yang X
    Parasit Vectors; 2017 May; 10(1):222. PubMed ID: 28482922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory Mechanisms.
    Marques A; Torre C; Pinto R; Sepodes B; Rocha J
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.
    Mei SH; Haitsma JJ; Dos Santos CC; Deng Y; Lai PF; Slutsky AS; Liles WC; Stewart DJ
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1047-57. PubMed ID: 20558630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen-Vacancy-Rich Monolayer BiO
    Liu F; Zhang K; Lu B; Wang X; Dong Q; Xue T; Tan Y; Wang X; Du J
    Adv Healthc Mater; 2024 Jul; 13(18):e2304002. PubMed ID: 38427842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 18. Maresins as novel anti-inflammatory actors and putative therapeutic targets in sepsis.
    Sun Y; Sun S; Chen P; Dai Y; Yang D; Lin Y; Yi L
    Pharmacol Res; 2024 Apr; 202():107113. PubMed ID: 38387744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory therapy for sepsis: an update.
    Christaki E; Anyfanti P; Opal SM
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1013-33. PubMed ID: 22029521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The critical role of neutrophil-endothelial cell interactions in sepsis: new synergistic approaches employing organ-on-chip, omics, immune cell phenotyping and
    Liu D; Langston JC; Prabhakarpandian B; Kiani MF; Kilpatrick LE
    Front Cell Infect Microbiol; 2023; 13():1274842. PubMed ID: 38259971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.